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Suntmary 
Many membrane proteins are implicated in the control of cell function by triggering spedfic 
signaling pathways. There is a new family of membrane proteins, defined by its structural motifs, 
which includes several lymphoid antigens, but lacks a function. To study its biological role, we 
determined which signaling pathways are affected by the CD53 antigen, a prototypic member 
of this family, in rat macrophages. Activation of CD53 by cross-linking results in an increase 
in inositol phosphates and diacylglycerol  and in Ca  z+  mobilization, which are insensitive to 
pertussis or cholera toxins. There is a translocation of protein kinase C to the membrane accompanied 
by nitric oxide (NO) release in macrophages. This effect is the result of the expression of the 
inducible nitric oxide synthase (iNOS), which is dependent on protein kinase C  and protein 
synthesis.  These results have linked a new receptor with a specific pathway of NO induction 
and thus have opened up a novel aspect of NO regulation in cell biology. 
new lymphoid family of membrane proteins is character- 
Aired  because its members are very hydrophobic and have 
four transmembrane domains; the NH2 and COOH termini 
are intracytoplasmic, and they are glycosylated in one of the 
two extracellular  domains (1). The family is known as the 
transmembrane 4  superfamily (TM4SF) 1 proteins.  Their 
structure is similar to that of connexins, the proteins forming 
gap  junctions (2). These new TM4SF proteins have been related 
to the control of cell proliferation or to the tumor pheno- 
type. Among the members of this family are CD37 (3), CD9 
(4), the murine antigen TAPA1 which is related to the prolifer- 
ative properties of T ceils (5, 6), the antigen OX44/CD53 
(7, 8), the human antigen ME491/CD63 which is a prog- 
nostic marker of melanoma (9, 10), the human antigen CO- 
029 originally detected in colon, rectal, gastric, and pancreatic 
carcinomas (11), the human R2 antigen present on most he- 
matopoietic cells (12), and the human IA4 antigen (13). Be- 
cause of the potential role they might play in the control of 
cell proliferation and differentiation, we tested the possibility 
that these proteins might be implicated in some signal trans- 
duction pathway and perhaps have a related biological prop- 
erty in all immune cells. To study this role, we chose the 
1 Abbreviations used in this  paper: DAG, 1,2-diacylglycerol;  iNOS, inducible 
form of nitric  oxide synthase;  InsP3, inositol(1,4,5)trisphosphate;  NO, 
nitric oxide; PDBu, phorbo112,13-dibutyrate;  t-But-HQ, 2,5-di(t-butyl)- 
1,4-benzohydroqninone;  TM4SF, transmembrane  4 superfamily. 
CD53 antigen because it is a panleukocyte antigen that is 
well characterized  in rat and humans (8,  14-16). 
The rat CD53 antigen is recognized by the mAb MRC 
OX-44 (7). This mAb defines a panleukocyte antigen mole- 
cule that is present in all mature cells of the immune system 
(1), including B and T  lymphocytes, macrophages, mono- 
cytes, and leukocytes (7, 17). The presence of CD53 antigen 
on so many different cell types might represent a function 
common to all of them. In T cells CD53 defines a functional 
subpopulation during thymic development (7,  17) and en- 
hances the cell response after stimulation of the TCR (17). 
In rat T  calls, CD53 gene expression  is induced by cross- 
linking of the T cell receptor (18) and CD53 coimmunoprecipi- 
tares with CD2 (15, 19) and modulates the associated tyro- 
sine kinase activity (19) in T and NK ceils. Recently, it has 
been shown that CD53 mediates signal transduction in human 
monocytes and B  cells including an increase  in cytosolic 
Ca  2+ and the expression of characteristic  responses such as 
the monocyte oxidative burst (20). Because in these studies 
CD53 was linked to important specific functions of mono- 
cytes, B or T cdls, we reasoned that perhaps a similar linkage 
might occur in macrophages. 
In the present work we show that CD53 is implicated in 
signal transduction in rat macrophages and induces the produc- 
tion of nitric oxide via a protein kinase C-dependent pathway. 
Nitric oxide plays a fundamental role in macrophage activa- 
tion where it has both communication and defensive func- 
tions (21, 22). 
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Reagents and Chemicals.  [U-14C]arginine,  T-[~zP]CTP  and the 
kits for the assay of cGMP and inositol(1,4,5)trisphosphate (InsPz) 
were from Amersham International (Amersham, UK). Adenosine 
2',5'-bisphosphate-Sepharose was from Pharmacia LKB (Uppsala, 
Sweden). LPS was from Difco Laboratories, Inc. (Detroit, MI), 
and Dowex AGSOW-X8 (Na+-form) was from Bio-Kad Labora- 
tories (Richmond, CA). Nitrate reductase  from AspergiUus  and other 
enzymes were from Boehringer Mannheim (Mannheim, Germany) 
or Sigma Chemical Co. (St. Louis, MO). BH4 was from Dr. B. 
Schircks Laboratories (Jona, Switzerland). 
mAbs.  mAb MRC OX-44 (anti-CD53) and MRC OX-34 (anti- 
CD2) were obtained from Dr. A. Williams (Oxford University, 
UK) and have been previously described (7, 23). As a negative con- 
trol we used monoclonal MARM (anti-rat IgM) from Serotec  (Ox- 
ford, UK). The three mAbs are of  the IgG1 isotype. For the prepa- 
ration of F(ab')2 fragments, the mAb OX-44 was digested with 
pepsin and further purified by protein A-Sepharose  chromatography 
following standard procedures (24). 
Cell Cultures.  Peritoneal  macrophages were prepared from male 
rats and ceUs were cultured in RPMI 1640 medium supplemented 
with 10~  of heat inactivated FCS (25). All cell culture material 
was from GIBCO BILL (Gaithersburg, MD). Experiments were 
carried out in phenol-red-free DME medium supplemented with 
1 mM arginine and 10% of heat inactivated FCS. 
Determination of the Intracellular Ca  2. Concentration.  Ca  2+ con- 
centration was measured in macrophages adhered to a coverslip  (0.7 
cm  z) and loaded with 5 #M tiara 2-AM at 37~  for 20 rain in the 
presence of 20 #g/m1 of pluronic acid. After extensive washing, 
the coverslip was placed in a 1.5-mi spectrofluorometric cuvette 
containing PBS, 0.5 mM CaCh, and 5 mg/ml of fatty acid-free 
BSA. The fluorescence  was recorded at 510 nm in a spectrofluorom- 
eter (L50; Perkin-Elmer Corp., Norwalk, CT) using a dual excita- 
tion source at 340 and 380 nm. The maximal fluorescence  was de- 
termined at the end of the assay by adding  10 #1 of 10% SDS. 
The minimal fluorescence  was obtained by adding 15 #1 of a solu- 
tion containing 0.5 M EGTA, 0.5 M Tris, pH 9.0, and the spectra 
were analyzed after data export to Lotus 123 program (25). 2,5- 
di(t-butyl)-l,4-benzohydroquinone (t-But-HQ) was used at 10 #M. 
When cholera (1 #g/ml) and pertussis (1 #g/m1) toxins were used, 
the cells were incubated with the toxins for 15 min before stimu- 
lation. 
InsPj and Diacylglycerol Determinations.  The intracellular con- 
centration of InsP3 was measured after extraction of the cell layer 
with 0.25 ml of ice-cold 0.5 M perchloric acid, and following the 
protocol of the kit supplier (Amersham International). To measure 
the 1,2-diacylglycerol  (DAG) from 3  x  106 cells in 6-cm dishes, 
the cell layers were homogenated with 0.5 ml of ice-cold meth- 
anol, to which one volume of Cl~HC/methanol (95:5) was added. 
After thorough mixing the tubes were centrifuged in a centrifuge 
(Eppendort) for 10 min at 4~  and the organic layer collected. 
The DAG content was measured by its conversion to phosphatidic 
acid by diacylglycerolkinase from Escherichia coli, in the presence 
of 3,-[32p]ATP and using  1,2-diotanoylglycerol as  internal  stan- 
dard (26). 
Protein Kinase C Determinations.  Macrophages (3  x  106 cells) 
were homogenized in 1 ml of  4 mM EDTA, 2 mM EGTA, 10 mM 
B-mercaptoethanol, 10 #g/m1 leupeptin, and 20 mM Tris, pH 7.5. 
After centrifugation at 105,000 g for 30 min the activity present 
in  the particulate  fraction  was extracted with homogenization 
medium supplemented with 0.1% NP-40. Both the sohble and 
the extracted fractions were purified by DE52 chromatography and 
the protein kinase C activity was assayed using histone H1 as sub- 
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strate (26, 27). Western blot analysis of  the particulate fraction was 
carried out using mAb specific  for the ol/BI/BII subspecies of  pro- 
tein kinase C  (Sdkagaku America, Inc., Kockvilh,  MD). 
CD53 and CD2 Analysis.  To evaluate the macrophage popula- 
tion expressing CD53 and CD2 antigens, the cells were adhered 
to a coverslip and analyzed by immunofluorescence using as sec- 
ondary antibody an FITC rat anti-mouse IgG1 antibody. At least 
95% of the population resulted positive for the staining with OX- 
44, and under these conditions <5% of the cells were positive for 
the secondary antibody. In our system, we observed that virtually 
all the macrophage population was positive for the expression of 
CD53 (OX-44) and negative for CD2 (OX-34). The quantitation 
was performed after scraping cells from the slide and passing them 
through the FACS  |  (Becton Dickinson & Co., Mountain  View, 
CA). 
Determination of NO (Nitric Oxide).  Total  NO release was de- 
termined by the accumulation in the culture medium of  nitrite and 
nitrate. Nitrates  were reduced to nitrites with nitrate reductase, 
and nitrites were determined with Griess reagent by adding I mM 
sulfanilic acid and 100 mM HC1 (final concentration) (27). After 
a first reading of the absorbance at 595 nm, naphthylenediamine 
(1 mM in the assay) was added. The reaction was completed after 
15 min of  incubation and the absorbance at 595 nm was compared 
with  a standard of NaNOz.  The absorbance corresponding  to 
samples stopped at time 0 of incubation was subtracted. 
Cell Homogenates and Adenosine 2',5'-Bisphosphate-Sepharose Chro- 
matography.  Macrophage homogenates were prepared in 2 ml of 
a medium containing 20 mM Tiffs,  pH 7.5 (4~  0.5 mM EGTA, 
0.5 mM EDTA, 1 mM 1,4-dithio-erythritol,  1/~M BH~, 1/zM 
leupeptin, and 0.2 mM phenylmethanesulfonyl  fluoride (homogeni- 
zation buffer). The cell homogenate was centrifuged at 20,000 g 
for 15 min, and the supernatant was partially purified by a 2',5'- 
ADP-Sepharose  column (0.5 x 5 cm) equilibrated  with homogeni- 
zation  buffer  supplemented with  1 mM  MgClz and  100 mM 
NaC1. After washing the column with this medium containing 
0.5 M NaC1 until no more protein emerged, nitric oxide synthase 
(NOS) activity was ehted in homogenized medium supplemented 
with 5 mM dicotinamide adenine dinucleotide phosphate (reduced) 
(NADPH) and 10% glycerol (vol/vol) (27). Fractions containing 
NOS activity were concentrated by uhrafiltration  through a cel- 
hilosetriacetate  membrane with a cut-off  of  30 kD (Sartorious, Got- 
tingen,  Germany).  The  presence  of  1  /zM  BH4  during  the 
purification was critical in maintaining an active enzyme. Enzyme 
assays were carried out immediately after purification. The protein 
concentration was measured in the pellet after ethanolic precipita- 
tion (28). 
Assay of  NOS Activity.  The enzyme was assayed  by the produc- 
tion of [U-l~C]citrulline from [U-14C]arginine (27) in a buffer that 
contained 20 mM Hepes (pH 7.4), 50 #M [U-l*C]arginine (0.3 
#Ci), 10 #M flavine adenine dinucleotide, 10/zM BH4, and 0.5 
mM NADPH (200 #1 of incubation volume). After 10 min of in- 
cubation, the reaction was stopped with I ml of an ice-cold solu- 
tion containing 10 mM EGTA, I mM citmlline, and 100 mM Pipes, 
pH 5.5.  1 ml of this  mixture was  applied to a  1 ml Dowex 
AGSOW-X8 column (Na+-form), and [U-l~C]citruUine  was eluted 
in 3 ml of water. The reaction was carried out at 30~  and the 
enzyme activity was expressed as the difference of product forma- 
tion in the absence or presence of 0.25 mM N~-methyl-L-arginine 
in the reaction mixture. When the effect of Ca  2+ on NOS activity 
was tested, the reaction mixture was incubated with 1 mM EGTA 
(basal activity) or in the presence of 10 #/ml calmodulin and 100 
/zM Ca  e* . 
Release in Macrophages Northern Blot Analysis of NOS.  RNA was extracted and ana- 
lyzed by Northern blot using a 2.4-kb SspI/EcoRI probe isolated 
from a HincII-SspI fragment  of NOS inserted into pUC19 (29). 
A Glyceraldehyde-3-phosphate  dehydrogenase  cDNA probe was used 
to normalize  the KNA load in gel lanes. 
Determination ofcGMP.  To measure cGMP, the cells were in- 
cubated in 9-cm dishes for 10 min before ligand addition with 0.5 
mM isobutyl-l-methylxanthine to prevent the degradation of  cGMP. 
The medium was aspirated and replaced by 1 ml of an ice-cold mix- 
ture of ethanol/water (2:1, vol/vol). After homogenization and cen- 
trifugation  in a centrifuge  (Eppendorf, Inc.), samples were speed 
vacuum-dried  and cGMP was measured using a specific binding 
kit, following the recommendation of the supplier (Amersham In- 
ternational). 
Results 
0X-44 and Its F(ab')2 Fragment Mobilize Ca  e+ in Rat Mac- 
rophages.  The identification of the early signals elicited after 
binding of extracellular ligands to membrane receptors is a 
useful approach to understand the pathways involved in the 
cellular response to the stimuli (30). To determine the signals 
generated  by  the  cross-linking  with  mAb  OX-44  or  its 
F(ab')z fragments in rat macrophages, we first measured the 
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Figure  1.  Intracellular  Ca  2+ increases after CD53 cross-linking  in rat 
macrophages. Cells were loaded with Fura-2A (5/~M) and after extensive 
washing were incubated  with mAb MRC OX-44 (A) or its purified 
F(ab')2 fragment  (B). (C) Dose dependence  effect of OX-44 on Ca  2  + 
mobilization.  (D) Effect of OX-44 on Ca  2+  mobilization after incuba- 
tion of the cells with t-But-HQ (10 #M). (E and F) Effect of treatment 
with cholera or pertussis toxins on Ca  2+ mobilization by OX-44.  MRC 
OX-44 was used at a concentration of 10/~g/ml. Arrows indicate the time 
at which additions  were made. Bars (A and B) correspond  to the SEM 
of five independent  determinations  at peak values. 
changes in the cytoplasmic Ca  2+ levels. Cross-linking results 
in  an  immediate  increase  in  cytosolic Ca  2+  from  the  en- 
doplasmic reticulum followed by a drop in its cytoplasmic 
level (Fig.  1 A). This suggests that CD53 cross-linking acts 
on Ca  2+ mobilization at several levels. Similar results were 
obtained by using purified OX-44 F(ab')2 fragments (Fig.  1 
B), suggesting that these effects are a consequence of antibody- 
mediated receptor cross-linking. No effect was detected when 
the Fc fragment or when another antibody of the same iso- 
type as OX-44, IgG1, was used (data not shown). The re- 
sponse in Ca  z + mobilization was dependent on the concen- 
tration  of OX-44 used (Fig.  1 C).  Based on this response 
curve, we selected to use OX-44 at a concentration of 10/~g/ml 
unless otherwise indicated. 
To confirm that the second phase of the response, the de- 
crease in cytosolic Ca  ~+  (Fig.  1, A  and B), was also a con- 
sequence of the cross-linklng,  we first released the endoplasmic 
reticulum pool with t-But-HO~ followed by the addition of 
mAb OX-44. In these conditions the mAb induces a reduc- 
tion of the cytosolic Ca  2+ (Fig.  1 D). The dual response that 
the antibody appears to exert points to an effect on the cell 
membrane, and this observation is in agreement with previous 
reports where complex effects on Ca  2+  mobilization  have 
been described (31).  We further  characterized  the possible 
type of G protein implicated in this activation by studying 
the effects of different toxins, such as cholera and pertussis. 
In these experiments the toxins at a concentration of I #/ml 
were added 15 rain before the addition of OX-44. In agree- 
ment with recent results in monocytes and B cells (20), nei- 
ther of the two toxins had an effect on mobilization of Ca  2+ 
(Fig.  1, E  and F),  ruling  out the involvement of Gc~s and 
Goti proteins, but not of other G proteins in the transmem- 
brahe signaling  through  CD53. 
0X-44 Activates the Production of InsP~ and DAG.  The 
mobilization  of intracellular  Ca  2+  suggested that  it might 
be the consequence of a signal generated by phospholipase 
C  activity (PLC). We therefore determined the level of the 
PLC reaction products,  InsP3 and DAG, after cross-linking 
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Figure  2.  Effect of mAb OX-44 on the levels  oflnsP3 (circles) and DAG 
(squares) in peritoneal rat macrophages stimulated with 10/~g/ml of OX-44 
(solid symbols) or 10 #g/ml of rabbit  anti-rat IgM (open symbols).  Both 
antibodies have the same isotypes (IgG1). Results show the means +  SEM 
of three  independent  experiments. 
1121  Bosc~ and Lazo with OX-44. We examined the changes taking place during 
the  120 s after mAb addition  to rat macrophages  (Fig.  2). 
The levels of InsP3 increased fivefold immediately, a pattern 
of response typical of PLC activation. The levels of DAG also 
increased at least fivefold, but did not drop immediately (Fig. 
2), suggesting the involvement of additional pathways, pos- 
sibly a phospholipase D activity, in its generation (our manu- 
script in preparation).  As Fig.  2  shows, macrophage  treat- 
ment with  an unrelated  monoclonal  antibody of the  same 
isotype failed to elicit  a response. 
Protein Kinase C  Is Involved in the 0X-44 Response.  The 
second messengers released  after CD53 activation, like Ca  2+ 
and DAG, are potential activators of protein kinase C.  The 
activation of protein kinase C results in changes in its subcel- 
lular localization between soluble and membrane bound forms. 
To determine if OX-44  stimulator  activates protein kinase 
C we measured the protein kinase C activity distribution be- 
tween the soluble and particulate fractions in macrophages. 
As shown in Fig.  3,  the addition  of the antibody changes 
the distribution  of protein kinase C  towards its particulate 
form.  This observation was further  confirmed by Western 
blot analysis  of the protein kinase C  protein present in the 
particulate fraction (Fig.  3,  insert) and was consistent with 
the redistribution of enzyme activity as a result of transloca- 
tion (activation)  after cross-linking with MRC OX-44 an- 
tibody. 
0X-44 Induces the Release of  NO in Macrophages.  In mac- 
rophages NO has been reported to be an important  effector 
molecule in response to several cytok4nes and endotoxins such 
as LPS (32),  and a protein kinase C-dependent  NO release 
has been observed in macrophages and hepatocytes (25, 27). 
Therefore,  we determined  the release  of NO as a result  of 
cross-linking of CD53 molecules with mAb MRC OX-44 
in rat macrophages.  As shown in Fig. 4, cross-linking with 
MRC OX-44 induces release  of NO to an extent similar to 
that of LPS, a known activator of NO production in macro- 
phages (33). Phorbol 12,13-dibutyrate (PDBu) is a phorbol 
ester that binds and activates protein kinase C, thus bypassing 
the need for an externally initiated signal, and it can be used 
to determine the full potential of the activation of this pro- 
tein kinase C. The combination of LPS or PDBu with mAb 
OX-44 did not have an additive effect, nor completely acti- 
vated the pathway.  Inhibitors  of protein  kinase  C,  such as 
H7 and calphostin C, prevented the induction of NO release 
after CD53 cross-linking. These data suggest that the CD53 
induction of NO release is mediated by protein kinase C and 
shares some common elements with the activation pathway 
triggered by LPS. The release of NO induced by CD53 cross- 
linking is also dependent on protein synthesis, as shown by 
its inhibition  by actinomycin D  or cycloheximide (Fig.  4). 
0X-44 Induces an Increase in the iNOS Activity.  NO is the 
reaction product of the NOS enzymatic activity (34).  Re- 
cently, it has been shown that  the activation of protein ki- 
nase C leads to the expression of the iNOS in macrophages 
(25), which is known to be induced by LPS or interferon-'), 
(33, 35).  To study whether OX-44 could affect the induc- 
tion of iNOS, we first performed the time course of this en- 
zyme activity as a result of CD53 cross-linking.  As shown 
in Fig. 5 A  there is an increase in NOS activity after incuba- 
tion with OX-44 that peaks at 4 h. This observation is con- 
sistent with the dependence on de novo protein synthesis for 
NO release previously shown by the use of protein synthesis 
inhibitors  (Fig.  4). There are two major types of NOS en- 
zymes (36);  one is inducible and  the other is constitutive, 
and they can be discriminated by the dependence of the con- 
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Figure 3.  Effect  of mAb OX-44 on protein kinase C activity  distribu- 
tion between  soluble  (open  ban, s) and particulate (dashed  bars,  p) fractions. 
The insert shows  the distribution of  protein kinase C of samples  collected 
at 0, 2, 5, and 10 min after OX-44 addition and analyzed by Western 
blot. The blot was revealed  using an anti-odBI/BII  protein kinase C anti- 
body. Results are the means +  SEM of three experiments. 
Figure 4.  Effect  of mAb OX-44 on the release of nitric oxide by rat 
macrophages incubated with protein kinase C modulators, endotoxins, 
and protein synthesis  inhibitors. Macrophages  were incubated for 6 h in 
the presence of the indicated ligands and the nitrite/nitrate release was 
measured with the Griess reagent. The nitrite content in unstimulated 
cells was 4.2  +  0.3 nmol/mg of protein. Similar results were obtained 
when the macrophages were stimulated with OX-44 F(ab')2 fragment. 
Results are the means +  SEM of three independent experiments. 
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Figure 5.  Effects  of OX-44 on NOS activity  (A) and cGMP  concen- 
tration (B). Macrophages  were  incubated  with 10/~g/ml of  MRC OX-44 
(solid symbols) or the isotype  control  an anti-rat IgM (open symbols). NOS 
activity  was measured  at saturant  concentrations  of  effectors  and substrates, 
and the activity  was independent  of Ca  2+ and calmodulin. Similar  results 
to those of OX-44 were obtained  with its F(ab')z  fragment.  Data are given 
as means +  SEM of three independent experiments. 
stitutive form on Ca  2+  and calmodulin for its activity. The 
assays were performed in the absence of Ca  2+ and calmodu- 
lin, and addition of 1 mM EGTA or Ca  2  + and calmodulin 
did not affect the activity. Taken together, these results indi- 
cate that the activity measured corresponded to iNOS. 
Furthermore, a consequence of NO production is the ac- 
tivation of guanylate cyclase (37). To determine whether this 
was indeed the case, we measured the cGMP levels after cross- 
linking with mAb OX-44 (Fig. 5 B). The cGMP levels were 
increased as expected and the changes paralleled the induc- 
tion of iNOS activity. 
To confirm that the isoenzyme of nitric oxide was the in- 
ducible form was the cause of the increased enzyme activity, 
we incubated macrophages with mAb OX-44 and its F(ab')2 
and determined the levels of mR.NA using a cDNA probe 
specific for the iNOS of macrophages (38, 39).  We deter- 
mined the specific iNOS RNA levels at several timepoints 
of incubation with OX-44 at 10 #g/ml. The result is shown 
in Fig.  6.  There is a peak in iNOS specific RNA between 
3 and 6 h, which is consistent with the enzyme activity levels 
reported above (Fig. 5 A). A similar increase in iNOS RNA 
Figure 6.  Incubation  of macrophages with OX-44 promotes the ex- 
pression of iNOS. Macrophages  (2 x  106)  were incubated  in the absence 
(-) or presence  (+) of 10/tg/ml of MRC OX-44 or F(ab')2, and the level 
of iNOS RNA was determined at different time points from the start 
of  the incubation.  The RNA load  in the gelwas normalized  by hybridiza- 
tion of the same blot with glyceraldehyde-3-phosphate  dehydrogenase 
(GAPDH)  cDNA  probe. The band intensity  was quantitated  by densitom- 
etry of the Northern blot, and after normalization  with GAPDH con- 
tent, the relative  intensities were plotted vs. the maximal ratio (100%). 
The figure shows one representative  out of three. 
was detected when the macrophages were stimulated with 
10 #g/ml of LPS (not  shown). 
Discussion 
CD53 is an ubiquitous antigen present on the membrane 
of all cells with a host defensive function (1). CD53 belongs 
to a membrane protein family, the TM4SF, which is highly 
conserved among its members and in different animal spe- 
cies, however its physiological role is very  poorly understood 
(1, 16). In this work we have attempted to define a pathway 
in rat macrophages that could link this antigen to a known 
biological property of this cell type. 
The immediate response to CD53 cross-linking, as shown 
by the effects of OX-44 or its F(ab')z fragment is the increase 
of intracellular Ca  2+ . This effect is complex and in addition 
to the mobilization of the intracellular stores, there is an ad- 
ditional target that results in the loss of the intracytoplasmic 
Ca  2+,  as shown by the effect of OX-44 in cells pretreated 
with t-But-HQ (Fig.  1 D).  This Ca  2+  mobilization in re- 
sponse to CD53 cross-linking is a common phenomenon to 
all cell types where it has been studied like monocytes, B, 
T, and NK cells, and consequently it might suggest a common 
transmembrane signaling in all these cells. Furthermore, this 
effect seems to be independent of the specific protein interac- 
tions that CD53 has on these cell types; thus in T  cells it 
upregulates the effects of CD2 responses (15). 
The activation of the InsP3/DAG pathway has been linked 
to two types of membrane proteins (30).  One with  seven 
transmembrane domains, such as neuropeptide receptors (30), 
is mediated by a specific type of Got proteins that can be dis- 
1123  Bosc~t and Lazo tinguished by the use of cholera and pertussis toxins, although 
other Gee proteins insensitive to both toxins (Ceq) have been 
reported (40).  The other with one transmembrane domain, 
like phtdet-derived growth factor and epidermal growth factor 
receptors, or complex receptors, like TCR, responds through 
tyrosine phosphoryhtion (30). However, the structure of these 
proteins is not related to any of the TM4SF type of proteins 
(16). Regarding CD53 it has been postulated that the OX- 
44/CD53 protein could form part of a channd for some small 
molecules (1), consistent with its structural homology to con- 
nexins (2).  Because the proteins of the TM4SF family, in- 
cluding CD53, lack SH domains and are not known to be 
phosphorylated in tyrosine residues (14), they can not bind 
an SH domain (41). Therefore the transmission of its signal 
must be mediated through a novel connecting protein to pro- 
tein kinases (42) that do not have a transmembrane domain 
(43). In the only TM4SF family member known to act through 
a tyrosine kinase mechanism, the TAPA-1 antigen in B cells, 
the connection is mediated through the CD19 molecule which 
has phosphorylated Tyr residues that can interact with SH2 
domains (44).  Tyrosine phosphorylation is an early event in 
the response to anti-TAPA-1 antibodies (44). Indeed, in human 
monocytes the Ca  2  + mobilization induced by anti-CD53 an- 
tibodies seems to be affected by genistein, a nonspecific tyro- 
sine kinase inhibitor (20).  Therefore, the ducidation of the 
nature of the connecting molecules between the CD53 an- 
tigen and specific kinases constitutes a critical step in the un- 
derstanding of the physiology of CD53 in each call type. 
Protein kinase C has been shown to be implicated in the 
induction of iNOS activity in rat hepatocytes treated with 
phorbol esters (26). In this work we have shown that protein 
kinase C activation after CD53 cross-linking triggers the ex- 
pression of iNOS in rat macrophages. Thus, it is very likely 
that those agents that modulate iNOS expression might be 
functioning through a protein kinase C-dependent pathway. 
The activation of the inducible form of iNOS by cross- 
linking of CD53 represents a novel mechanism by which this 
enzyme is regulated in macrophages where NO plays a key 
role in the response to infection and to tumor cells (21). This 
finding is important because CD53 is present in all mature 
types of the lymphoid lineage, including B and T cells, both 
in rats and humans. However, there must be differences in 
the function CD53 plays in each of these cell types. In rat 
T  and NK cells, CD53 coprecipitates with CD2 and it en- 
hances the response to the stimulation mediated by the T 
cell receptor (18, 19). In humans and rat, both macrophages 
and B cells are CD2 negative and lack TCR, thus CD53 in- 
teracts variously on the membrane and the functional differ- 
ences are unknown regarding the specific aspects of the re- 
sponse to CD53 cross-linking among different cell types. Since 
the nature of the CD53 ligand is unknown, its identification 
will lead to a better understanding of NO biology. If other 
proteins of the same family such as CD53 also modulate the 
NO metabolism, new opportunities for research into this mol- 
ecule and its role in cellular physiology will be opened. Un- 
derstanding NO regulation will lead to the new knowledge 
about the modulation of cell communication in the immune 
system, and perhaps to a better management of clinical con- 
ditions such as hemorraghic and septic shocks where NO 
is implicated (45).  Nitric oxide besides its cytotoxic activity 
may have other functions in macrophageg like inducing vasodi- 
lation and tissue damage. 
In this report we have demonstrated that in macrophages 
CD53 antigen cross-linking can induce the expression ofiNOS 
and the release of NO through a protein kinase C-depen- 
dent pathway. Based on this work and in other reports on 
the effects of CD53 in monocytes, B and T cells, we can postu- 
late that CD53 is a regulator of the specific functions of each 
cell type belonging to the immune systems. 
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